Heterocyklusderivater med 5 led, fremstilling og anvendelse deraf som lægemidler

Five-membered heterocycles (III) in racemic or enantiomeric form, and their mixtures and their salts are new. Five-membered heterocycles of formula (III) in racemic or enantiomeric form, and their mixtures and their salts are new: [Image] Het : 5-membered heterocycle with 2 heteroatoms, such that (I...

Full description

Saved in:
Bibliographic Details
Main Authors THURIEAU, CHRISTOPHE, LIBERATORE, ANNE MARIE, HARNETT, JEREMIAH, BIGG, DENNIS, LANNOY, JACQUES, POMMIER, JACQUES, CHABRIER DE LASSAUNIERE, PIERRE ETIENNE
Format Patent
LanguageDanish
Published 10.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Five-membered heterocycles (III) in racemic or enantiomeric form, and their mixtures and their salts are new. Five-membered heterocycles of formula (III) in racemic or enantiomeric form, and their mixtures and their salts are new: [Image] Het : 5-membered heterocycle with 2 heteroatoms, such that (III) is of formula (IIIa) - (IIId); A : alkyl, cycloalkyl, cycloalkylalkyl or a group of formula (A1), (A2), (A3), (A4) or (A5); R 3> : H, OH, alkoxy, or alkyl; R 4> - R 8> : H, halogen, OH, alkyl, alkoxy, CN, NO 2, or NR 1> 0>R 1> 1>; R 1> 0> and R 1> : H, alkyl, or -COR 1> 2>, or together with the N atom they form a 4-7 membered heterocycle with 1-3 heteroatoms; R 1> 2> : H, alkyl, alkoxy or NR 1> 3>R 1> 4>; R 1> 3> and R 1> 4> : H, alkyl; or R 1> 3> and R 1> 4> together with N atom : 4-7 membered heterocycle with 1-3 heteroatoms; R 9> : H, alkyl, or -COR 1> 5>; R 1> 5> : H, alkyl, alkoxy, or -NR 1> 6>R 1> 7>; R 1> 6> and R 1> 7> : H, alkyl, or together with the N atom they form a 4-7 membered heterocycle with 1-3 heteroatoms; W' is either not present or it : a bond, -O-, -S-, or -NR 1> 8>-; R 1> 8> : H or alkyl; Q : H, -OR 2> 2>, -SR 2> 2>, -NR 2> 3>R 2> 4>, phenyl (optionally substituted by halogen, OH, CN, NO 2, alkyl, alkoxy, -NR 1> 0>R 1> 1>, methylene dioxy or ethylene dioxy), or -COPh, -SO 2Ph, -CH 2Ph (these being optionally substituted on the aromatic ring by alkyl, alkoxy or halogen); R 2> 2> : H, alkyl, or aryl (optionally substituted by alkyl, OH, halogen, NO 2, or alkoxy); R 2> 3> and R 2> 4> : H, alkyl, or -COR 2> 5>; R 2> 5> : alkyl; R 1> 9>, R 2> 0> and R 2> 1> : H, halogen, OH, -SR 2> 6>, alkyl, cycloalkyl, alkenyl, alkoxy, CN, NO 2, -SO 2-NHR 4> 9>, -CONHR 5> 5>, -S(O) q-R 5> 6>, -NH(CO)R 5> 7>, -CF 3, -OCF 3, or -NR 2> 7>R 2> 8>; R 2> 6> : H or alkyl; R 2> 7> and R 2> 8> : H, alkyl, -COR 2> 9>, or together with the N atom they form a 4-7 membered heterocycle with 1-3 heteroatoms; R 4> 9> and R 5> 0> : H, alkyl or alkylcarbonyl; q : 0, 1, or 2; R 5> 6> and R 5> 7> : H, alkyl or alkoxy; R 2> 9> : H, alkyl, alkoxy or -NR 3> 0>R 3> 1>; R 3> 0> and R 3> 1> : H, alkyl, or together with the N atom they form a 4-7 membered heterocycle with 1-3 heteroatoms; R 3> 2> : H or alkyl; T' : methylene or ethylene; R 3> 3> : H, alkyl, - -NR 3> 4>R 3> 5>, or - -CHR 3> 6>R 3> 7>; : 1-6C alkylene; R 3> 4> and R 3> 5> : H or alkyl; R 3> 6> and R 3> 7> : H, carbocyclic or heterocyclic aryl, (optionally substituted by alkyl, OH, halogen, NO 2, alkoxy, or NR 1> 0>R 1> 1>); X : S or -NR 3> 8>; R 3> 8> : H, alkyl, cyanoalkyl, aralkyl, alkylcarbonyl, or aralkylcarbonyl; Y' : O or S; R 1> : H, alkyl, aminoalkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, trifluoromethyl alkyl, alkenyl, allenyl, allenylalkyl, allynyl, cyanoalkyl, -(CH 2) g-Z 1>R 3> 9>, -(CH 2) g-COR 4> 0>, -(CH 2) g-NHCOR 70>, aryl, aralkyl, arylcarbonyl, heteroaryl alkyl, aralkylcarbonyl, (aryl groups in these being optionally substituted by alkyl, halogen, alkoxy, nitro, CN, cyanoalkyl, amino, alkylamino, dialkylamino, -(CH 2) k-Z 2>R 3> 9> or -(CH 2) k-COR 4> 0>); and R 2> : H, alkyl, aminoalkyl, alkoxyalkyl, cycloalkyl, trifluoromethyl alkyl, -(CH 2) g-NHCOR 7> 1> (aryl and heteroaryl groups being optionally substituted by halogen, alkyl, alkoxy, OH, CN, NO 2, amino, mono- or dialkylamino); or R 1> and R 2> may together form : a 3-7 membered carbocycle; Z 1> and Z 2> : a bond, -O-, -NR 4> 1>-, or -S-; R 3> 9> and R 4> 1> : H, alkyl, alkenyl, alkynyl, or cyanoalkyl; R 4> 0> : H, alkyl, allenyl, allenylalkyl, alkenyl, alkynyl, cyanoalkyl, alkoxy, or -NR 4> 2>R 4> 3>; R 4> 2> and R 4> 3> : H, alkyl, allenyl, allenylalkyl, alkenyl, alkynyl, or cyanoalkyl; R 7> 0> and R 7> 1> : alkyl or alkoxy; B' : H, alkyl, -(CH 2) g-Z 3>R 4> 4>, or a carbocyclic aryl group that may be substituted 1-3 times by halogen, alkyl, alkoxy, OH, CN, NO 2, amino, alkylamino, dialkylamino or carbocyclic aryl; Z 3> : bond, -O-, -NR 4> 5>-, or -S-; R 4> 4> and R 4> 5> : H, alkyl, alkenyl, alkynyl, allenyl, allenyl alkyl, or cyanoalkyl; L* : NR 4> 6>R 4> 7> or -OR 4> 8>; R 4> 6> and R 4> 7> : H, alkyl, cycloalkyl, alkenyl, alkynyl, allenyl, allenylalkyl, cyanoalkyl, -(CH 2) g-Z 4>R 5> 0>, -(CH 2) k-COR 5> 1>, -(CH 2) k-COOR 5> 1>, -(CH 2) k-CONHR 5> 1>, -SO 2R 5> 1>, aryl, aralkyl, aryloxyalkyl, arylcarbonyl, arylimino, aralkyl carbonyl, or heteroaryl (the aryl and heteroaryl groups being optionally substituted by halogen, alkyl, alkoxy, OH, CN, NO 2, cyanoalkyl, amino, mono- or dialkylamino), -(CH 2) k-Z 5>R 5> 0>, -(CH 2) k-COR 5> 1>, or -(CH 2) k-COOR 5> 1>) or R 4> 6> and R 4> 7> taken together with the N atom form a 4-8 membered non-aromatic heterocycle (optionally interupted by -CH(R 53>)-, -NR 54>-, -O-, -S- or -CO); Z 4> and Z 5> : a bond, -O-, -NR 5> 2>- or -S-; R 50> and R 52> : H, alkyl, alkenyl, alkynyl, allenyl, allenylalkyl, or cyanoalkyl; R 5> 1> : H, cycloalkyl, cycloalkylalkyl, alkyl, alkenyl, alkynyl, allenyl, allenylalkyl, cyanoalkyl, alkoxyalkyl, NR 5> 8>R 5> 9>, aryl, or aralkyl; R 5> 8> and R 5> 9> : H, alkyl, alkenyl, alkynyl, allenyl, allenylalkyl, or cyanoalkyl; R 5> 3> and R 5> 4> : H, -(CH 2) k-Z 7>R 6> 0> or -CH 2) k-COR 6> 1>; Z 7> : a bond, -NR 6> 2>-, or -S-; R 6> 0> and R 6> 2> : H, alkyl, alkenyl, allenyl, allenyl alkyl, alkynyl, or cyanoalkyl, aryl, aralkyl, arylcarbonyl, aralkylcarbonyl, pyridinyl, pyridinylalkyl, pyridinylcarbonyl, (aryl and pyridinyl groups being optionally substituted by halogen, alkyl, alkoxy, cyanoalkyl, -(CH 2) k-Z 8>R 6> 3>,or -(CH 2) k-COR 6> 4>); R 6> 1> : H, alkyl, allenyl, allenyl alkyl, alkenyl, alkynyl, cyanoalkyl, alkoxy or -NR 6> 5>R 6> 6>; R 6> 5> and R 6> 6> : H, alkyl, allenyl, allenyl alkyl, alkenyl, alkynyl, or cyanoalkyl; Z 8> : -O-, -S- or -NR 6> 7>-; R 6> 3> and R 6> 7> : H, alkyl, allenyl, allenyl alkyl, alkenyl, alkynyl, or cyanoalkyl; R 6> 4> : H, alkyl, allenyl alkyl, alkenyl, alkynyl, cyanoalkyl, alkoxy or -NR 6> 8>R 6> 9>; R 6> 8> and R 6> 9> : H, alkyl, allenyl, allenyl alkyl, alkenyl, alkynyl, or cyanoalkyl; R 4> 8> : H, alkyl, alkynyl, or cyanoalkyl; g, p : 1 - 6; k, n : 0 - 6 [Image] Provisos apply, please see DEFINITIONS An independent claim is included for the use of (III), with the proviso that when (III) is (IIIA) then A is 4-hydroxy-2,3-di-tertiary butyl phenyl, B, R 1> and R 2> are H, and L* = OH, to make pharmaceutical compositions. ACTIVITY : Antiviral; antiinflammatory; analgesic; anticonvulsant, antiparkinsonian; cerebroprotective; hemostatic; nootropic; neuroprotective; neuroleptic; antimigraine; anabolic; anti-HIV, antidiabetic; cytostatic; dermatological; immunosuppressive. MECHANISM OF ACTION : Monoamine oxidase inhibitor; lipidic peroxidation inhibitor; sodium channel modulator.
Bibliography:Application Number: DK20050076749T